Delivery Order SPE2DB22D2214-SPE2DB25FS6QA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Visipaque 320 mg/ml infusion bottles (150 ml units) with a ceiling value of $4,126.40. This firm fixed-price delivery order, which is expected to be completed by August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order valued at $1,650.56 to AmerisourceBergen Drug Corp for Visipaque 320 mg/mL intravenous solution in 150 mL bottles. This competitive award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, reflects a firm fixed-price contract type with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $3,301.12 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml infusion bottles (150 ml units). This firm fixed-price delivery order, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,038.55 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/mL infusion bottles (150 mL units). This firm fixed-price delivery order, awarded on August 15, 2025, represents a non-competitive set-aside procurement and will be fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. Visipaque is a contrast medium used in...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/mL in 100 mL bottles with a ceiling value of $4,216.05 on August 29, 2025. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and carries no set-aside designation. The order was competitively awarded and represents a child contract under AmerisourceBergen's larger contract vehicle with the Defense Logistics Agency. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Visipaque 270 mg/ml in 150 ml bottles, valued at $1,599.09 with a firm fixed price arrangement. The contract requires completion by September 8, 2025, and represents a non-set-aside award issued through open competition. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99...
- The Defense Logistics Agency awarded a delivery order valued at $4,283.00 to AmerisourceBergen Drug Corp for the supply of Visipaque 270 mg/ml in 100ml bottles. The contract, awarded on May 22, 2025, with an ultimate completion date of May 23, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performing location for this order. This delivery order is issued under AmerisourceBergen...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $10,053.00 firm fixed-price delivery order by the Defense Logistics Agency on June 17, 2025, for the supply of Visipaque 320 mg/ml in 100ml bottles. The contract is a non-set-aside competitive award with an ultimate completion date of June 18, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This $999,999,999.00 prime...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,296.38 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml in 100ml bottles. This competitively awarded, firm fixed price contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $2,002.68, for Visipaque 320 mg/ml in a 100 ml bottle. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, issued on July 29, 2025. The award is non-competitive set-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6QADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,650.56 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml infusion bottles (150 ml) on September 19, 2025, with completion scheduled for September 22, 2025. This firm fixed-price delivery order, issued without a set-aside designation, was competitively awarded and represents a standard pharmaceutical procurement under the agency's medical supply chain operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and fulfills this order from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and related supplies across multiple therapeutic domains. The contract serves customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key supplier within the Department of Defense's medical logistics infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/19/25 |